| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,116 |
840 |
$55K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,161 |
887 |
$16K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,146 |
876 |
$14K |
| 90480 |
|
205 |
204 |
$8K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
470 |
469 |
$7K |
| 91320 |
|
48 |
48 |
$6K |
| 0124A |
|
105 |
105 |
$4K |
| 0134A |
|
99 |
99 |
$3K |
| 0054A |
|
83 |
83 |
$3K |
| 91322 |
|
20 |
20 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
51 |
45 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
282 |
191 |
$1K |
| 0064A |
|
31 |
31 |
$900.00 |
| 0111A |
|
14 |
14 |
$440.00 |
| 90756 |
|
30 |
29 |
$353.85 |
| 0074A |
|
13 |
13 |
$280.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
50 |
48 |
$48.53 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12 |
12 |
$13.85 |
| 91321 |
|
12 |
12 |
$0.00 |